CLINICAL_TRIALS
trial_result
· 2012-12-13
Clinical Trial Update: Study of SU11248 in Men With Advanced Prostate Cancer [Phase 2]
Summary
Phase 2 trial of SU11248 (sunitinib) in men with advanced prostate cancer has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-12-13